← Leaderboards
Joseph C Wu
Stanford University
$80,370,369
Attributed
$129,150,469
Total exposure
54
Grants
48
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$145,780,689 · 55
By mechanism
R01$68,461,095 · 19
P01$28,560,493 · 10
U01$14,489,368 · 3
R24$8,753,593 · 1
UG3$6,737,603 · 4
RC1$3,999,245 · 4
Top collaborators
- Thomas None Quertermous33 shared
- Wing H. Wong17 shared
- Lei Stanley Qi12 shared
- Mark Mercola11 shared
- Marlene Rabinovitch11 shared
- Michael P Snyder11 shared
- Koen Nieman10 shared
- John M. Pauly10 shared
Most similar at Stanford University
Same institution · by research overlap
- Gregory S. Barsh$28,951,512
- Nazish Sayed$4,856,076
- Mark Mercola$44,191,191
- Aly Elezaby$331,344
- Lei Stanley Qi$14,888,989
Others in their field
Top investigators on “Induced Pluripotent Stem Cell”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$77,143,245
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$72,554,837
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$50,800,152
- Li-Huei Tsai · Massachusetts Institute Of Technology$37,797,465
- David A Bennett · Rush University Medical Center$34,095,221
Research focus
Induced Pluripotent Stem CellCellsCardiac MyocytesCardiacMolecularGenesCardiovascular SystemHeartPhenotypeTechnologyResearch PersonnelCardiovascular DiseasesEndothelial CellsCell LineFutureGenomicsBaseGrantGeneticStem CellsCell TypeHeart FailureAffectPharmaceutical Preparations
Grant awards (200)
Assessing Effects of Microgravity on Cardiovascular Aging with AI and 3D Organoids$3,183,188
UG3 · FY2025 · TR · contact PI
Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology$2,369,947
P01 · FY2025 · HL · contact PI
AI-driven Drug Discovery Targeting Cardiac Fibrosis in Aging Heart$900,195
UG3 · FY2025 · AG · contact PI
Mechanisms of Cardiotoxicity Associated with Covalent Kinase Inhibitors$811,348
P01 · FY2025 · HL · contact PI
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens$769,543
R01 · FY2025 · HL · contact PI
Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs$766,771
R01 · FY2025 · HL · contact PI
Unraveling Proteasome Inhibitor-Induced Cardiovascular Toxicity through Integrative Multiomics$717,246
R01 · FY2025 · HL · contact PI
Modeling Susceptibility to Radiation Therapy-induced Cardiotoxicity Using Cell Village iPSCs$690,134
R01 · FY2025 · HL · contact PI
Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy$678,661
R01 · FY2025 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$676,392
R01 · FY2025 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$675,266
R01 · FY2025 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$657,101
R01 · FY2025 · HL · contact PI
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)$604,863
UH3 · FY2025 · HL
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$603,459
R01 · FY2025 · HL · contact PI
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation$599,975
R01 · FY2025 · HL · contact PI
Elucidating Sex Differences in Radiation-induced Cardiotoxicity with Cell Village iPSCs$550,479
U01 · FY2025 · AI · contact PI
Elucidating Genetic Susceptibility of Covalent Kinase Inhibitors with iPSC "Cell Village"$494,649
P01 · FY2025 · HL · contact PI
Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program$401,041
R38 · FY2025 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$196,200
T32 · FY2025 · EB · contact PI
Stanford Undergraduate Summer Cardiovascular Research Program$165,812
R25 · FY2025 · HL · contact PI
Administrative Core$161,351
P01 · FY2025 · HL · contact PI
Stanford Cardiovascular Summer Research Training Program for Medical Students$109,908
T35 · FY2025 · HL · contact PI
Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology$2,415,648
P01 · FY2024 · HL · contact PI
Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs$776,035
R01 · FY2024 · HL · contact PI
Modeling Susceptibility to Radiation Therapy-induced Cardiotoxicity Using Cell Village iPSCs$697,854
R01 · FY2024 · HL · contact PI
Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy$672,653
R01 · FY2024 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$669,033
R01 · FY2024 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$668,711
R01 · FY2024 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$653,214
R01 · FY2024 · HL · contact PI
Mechanisms of Cardiotoxicity Associated with Covalent Kinase Inhibitors$627,300
P01 · FY2024 · HL · contact PI
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$599,103
R01 · FY2024 · HL · contact PI
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation$597,054
R01 · FY2024 · HL · contact PI
Elucidating Genetic Susceptibility of Covalent Kinase Inhibitors with iPSC "Cell Village"$584,552
P01 · FY2024 · HL · contact PI
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$583,765
R01 · FY2024 · HL · contact PI
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)$579,494
UG3 · FY2024 · HL
Elucidating Sex Differences in Radiation-induced Cardiotoxicity with Cell Village iPSCs$539,081
U01 · FY2024 · AI · contact PI
Administrative Core$192,268
P01 · FY2024 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$166,163
R25 · FY2024 · HL · contact PI
Stanford Cardiovascular Summer Research Training Program for Medical Students$149,745
T35 · FY2024 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$112,862
T32 · FY2024 · EB · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$91,808
R01 · FY2024 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$58,141
R01 · FY2024 · HL · contact PI
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models$2,366,100
P01 · FY2023 · HL · contact PI
Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy$696,320
R01 · FY2023 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$691,803
R01 · FY2023 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$690,558
R01 · FY2023 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$675,989
R01 · FY2023 · HL · contact PI
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$620,773
R01 · FY2023 · HL · contact PI
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation$618,158
R01 · FY2023 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$601,810
R01 · FY2023 · HL · contact PI
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$595,679
R01 · FY2023 · HL · contact PI
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)$576,471
UG3 · FY2023 · HL
iPSC-CM Modeling to Define Sodium-Calcium Dysfunction in Heart Failure$513,960
P01 · FY2023 · HL · contact PI
Elucidating CHD in Down Syndrome with Cardiac Organoids and 3D Genome Architecture$385,799
R01 · FY2023 · HL · contact PI
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program$328,585
R38 · FY2023 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$327,935
T32 · FY2023 · EB · contact PI
Admin Core (Wu)$203,960
P01 · FY2023 · HL · contact PI
Stanford Cardiovascular Summer Research Training Program for Medical Students$144,561
T35 · FY2023 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,479
R25 · FY2023 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$91,977
R01 · FY2023 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$64,282
R01 · FY2023 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in DCM - Diversity Supplement$33,899
R01 · FY2023 · HL · contact PI
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models$2,366,100
P01 · FY2022 · HL · contact PI
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$768,819
R01 · FY2022 · HL · contact PI
Genetic and Stem Cell Model of Cardiac Metabolic Disease$735,262
R01 · FY2022 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$701,247
R01 · FY2022 · HL · contact PI
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$696,854
R01 · FY2022 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$683,859
R01 · FY2022 · HL · contact PI
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$675,692
R01 · FY2022 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$669,679
R01 · FY2022 · HL · contact PI
Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics$628,643
R01 · FY2022 · HL · contact PI
Modeling Cardiovascular Risks of Air Pollutants with Human Induced Pluripotent Stem Cell-Derived Cardiovascular-Associated Cells (Project 3) for the Air pollution disrupts Inflammasome Regulation in$620,156
P01 · FY2022 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$609,635
R01 · FY2022 · HL · contact PI
iPSC-CM Modeling to Define Sodium-Calcium Dysfunction in Heart Failure$513,960
P01 · FY2022 · HL · contact PI
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program$335,366
R38 · FY2022 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$215,439
T32 · FY2022 · EB · contact PI
Admin Core (Wu)$203,960
P01 · FY2022 · HL · contact PI
Effect of Microgravity on Drug Responses Using Engineered Heart Tissues$196,612
UH3 · FY2022 · TR · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$162,105
T32 · FY2022 · EB · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$128,566
R01 · FY2022 · HL · contact PI
Stanford Cardiovascular Summer Research Training Program for Medical Students$112,596
T35 · FY2022 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,443
R25 · FY2022 · HL · contact PI
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models$2,366,100
P01 · FY2021 · HL · contact PI
Genetic and Stem Cell Model of Cardiac Metabolic Disease$786,697
R01 · FY2021 · HL · contact PI
Effect of Microgravity on Drug Responses Using Engineered Heart Tissues$714,532
UH3 · FY2021 · TR · contact PI
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$684,695
R01 · FY2021 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$669,679
R01 · FY2021 · HL · contact PI
Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids$668,755
R01 · FY2021 · HL · contact PI
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening$627,358
R01 · FY2021 · HL · contact PI
Modeling Cardiovascular Risks of Air Pollutants with Human Induced Pluripotent Stem Cell-Derived Cardiovascular-Associated Cells (Project 3) for the Air pollution disrupts Inflammasome Regulation in$620,255
P01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$618,242
R01 · FY2021 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$610,051
R01 · FY2021 · HL · contact PI
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes$566,573
R01 · FY2021 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$562,562
R01 · FY2021 · HL · contact PI
iPSC-CM Modeling to Define Sodium-Calcium Dysfunction in Heart Failure$513,960
P01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies: Administrative Supplement (INCLUDE)$501,316
R01 · FY2021 · HL · contact PI
Modeling Anthracycline-Induced Cognitive Impairment Using iPSC-Derived Brain-On-Chips$393,607
R01 · FY2021 · HL · contact PI
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program$341,990
R38 · FY2021 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$305,472
T32 · FY2021 · EB · contact PI
Admin Core (Wu)$203,960
P01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$156,852
R01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$121,848
R01 · FY2021 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$106,797
R25 · FY2021 · HL · contact PI
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models$2,366,100
P01 · FY2020 · HL · contact PI
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes$882,881
R01 · FY2020 · HL · contact PI
Genetic and Stem Cell Model of Cardiac Metabolic Disease$750,912
R01 · FY2020 · HL · contact PI
Effect of Microgravity on Drug Responses Using Engineered Heart Tissues$720,589
UH3 · FY2020 · TR · contact PI
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$692,649
R01 · FY2020 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$677,504
R01 · FY2020 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$625,285
R01 · FY2020 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$580,336
R01 · FY2020 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$575,237
R01 · FY2020 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$537,363
R01 · FY2020 · HL · contact PI
iPSC-CM Modeling to Define Sodium-Calcium Dysfunction in Heart Failure$513,960
P01 · FY2020 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$481,020
R01 · FY2020 · HL · contact PI
Molecular Imaging of Cardiac Pluripotent Stem Cells$469,746
R01 · FY2020 · HL · contact PI
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program$348,455
R38 · FY2020 · HL · contact PI
Admin Core (Wu)$203,960
P01 · FY2020 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$176,921
T32 · FY2020 · EB · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,430
R25 · FY2020 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$83,587
R01 · FY2020 · HL · contact PI
Genetic and Stem Cell Model of Cardiac Metabolic Disease$53,214
R01 · FY2020 · HL · contact PI
Emerging Opportunities in Cardiovascular Disease$10,000
R13 · FY2020 · HL · contact PI
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models$2,380,225
P01 · FY2019 · HL · contact PI
Genetic and Stem Cell Model of Cardiac Metabolic Disease$758,244
R01 · FY2019 · HL · contact PI
Effect of Microgravity on Drug Responses Using Engineered Heart Tissues$731,772
UG3 · FY2019 · TR · contact PI
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$701,120
R01 · FY2019 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$688,459
R01 · FY2019 · HL · contact PI
iPSC-CM Modeling to Define Sodium-Calcium Dysfunction in Heart Failure$642,755
P01 · FY2019 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$587,417
R01 · FY2019 · HL · contact PI
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes$584,687
R01 · FY2019 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$578,512
R01 · FY2019 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$547,608
R01 · FY2019 · HL · contact PI
Assessment of Low-Dose Radiation Risk and Mechanisms of Individual Radiosensitivity$475,664
R01 · FY2019 · HL · contact PI
Molecular Imaging of Cardiac Pluripotent Stem Cells$474,504
R01 · FY2019 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies$395,000
R01 · FY2019 · HL · contact PI
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes: Down Syndrome Administrative Supplement$311,588
R01 · FY2019 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$235,180
T32 · FY2019 · EB · contact PI
Admin Core (Wu)$156,055
P01 · FY2019 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$103,618
R25 · FY2019 · HL · contact PI
Integrative Approaches to Complex Cardiovascular Diseases$30,000
R13 · FY2019 · HL · contact PI
Biorepository of Human iPSCs for Studying Dilated and Hypertrophic Cardiomyopathy$1,699,925
R24 · FY2018 · HL · contact PI
Effect of Microgravity on Drug Responses Using Engineered Heart Tissues$766,483
UG3 · FY2018 · TR · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$730,325
R01 · FY2018 · HL · contact PI
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes$601,173
R01 · FY2018 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$597,085
R01 · FY2018 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$596,600
R01 · FY2018 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$555,144
R01 · FY2018 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$515,616
R01 · FY2018 · HL · contact PI
Molecular Imaging of Cardiac Pluripotent Stem Cells$479,441
R01 · FY2018 · HL · contact PI
Assessment of Low-Dose Radiation Risk and Mechanisms of Individual Radiosensitivity$475,664
R01 · FY2018 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies$395,000
R01 · FY2018 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$250,686
T32 · FY2018 · EB · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$8,753
R01 · FY2018 · HL · contact PI
Biorepository of Human iPSCs for Studying Dilated and Hypertrophic Cardiomyopathy$1,797,180
R24 · FY2017 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$746,125
R01 · FY2017 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$515,616
R01 · FY2017 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$502,400
R01 · FY2017 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$492,582
R01 · FY2017 · HL · contact PI
Molecular Imaging of Cardiac Pluripotent Stem Cells$484,238
R01 · FY2017 · HL · contact PI
Assessment of Low-Dose Radiation Risk and Mechanisms of Individual Radiosensitivity$475,664
R01 · FY2017 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies$395,000
R01 · FY2017 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$223,338
T32 · FY2017 · EB · contact PI
Biorepository of Human iPSCs for Studying Dilated and Hypertrophic Cardiomyopathy$1,861,860
R24 · FY2016 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$758,646
R01 · FY2016 · HL · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$515,616
R01 · FY2016 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$492,582
R01 · FY2016 · HL · contact PI
Molecular Imaging of Cardiac Pluripotent Stem Cells$488,922
R01 · FY2016 · HL · contact PI
Assessment of Low-Dose Radiation Risk and Mechanisms of Individual Radiosensitivity$475,664
R01 · FY2016 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies$395,000
R01 · FY2016 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$393,018
R01 · FY2016 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$229,813
T32 · FY2016 · EB · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$99,999
R01 · FY2016 · HL · contact PI
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease$2,160,049
U01 · FY2015 · HL
Biorepository of Human iPSCs for Studying Dilated and Hypertrophic Cardiomyopathy$1,734,196
R24 · FY2015 · HL · contact PI
Induced pluripotent stem cells in the understanding and treatment of heart disease$1,175,736
U01 · FY2015 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$786,927
R01 · FY2015 · HL · contact PI
Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms$780,905
P01 · FY2015 · GM · contact PI
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy$515,616
R01 · FY2015 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$485,193
R01 · FY2015 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$387,104
R01 · FY2015 · HL · contact PI
Molecular Imaging of Targeted Cardiac Gene Therapy$262,667
R01 · FY2015 · HL · contact PI
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford$148,891
T32 · FY2015 · EB · contact PI
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease$8,140
U01 · FY2015 · HL
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease$2,290,099
U01 · FY2014 · HL
Biorepository of Human iPSCs for Studying Dilated and Hypertrophic Cardiomyopathy$1,660,432
R24 · FY2014 · HL · contact PI
Induced pluripotent stem cells in the understanding and treatment of heart diseas$1,170,141
U01 · FY2014 · HL · contact PI
Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms$764,270
P01 · FY2014 · GM · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$492,582
R01 · FY2014 · HL · contact PI
Molecular Imaging of Targeted Cardiac Gene Therapy$392,000
R01 · FY2014 · HL · contact PI
Integrated Strategies for Novel Treatment of Myocardial Ischemia$389,236
R01 · FY2014 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$385,120
R01 · FY2014 · HL · contact PI
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease$2,223,752
U01 · FY2013 · HL
Induced pluripotent stem cells in the understanding and treatment of heart diseas$1,134,896
U01 · FY2013 · HL · contact PI
Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms$819,340
P01 · FY2013 · GM · contact PI
Molecular Imaging of Targeted Cardiac Gene Therapy$389,616
R01 · FY2013 · HL · contact PI
Integrated Strategies for Novel Treatment of Myocardial Ischemia$378,072
R01 · FY2013 · HL · contact PI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$374,100
R01 · FY2013 · HL · contact PI
Re-Education of the Immune System for hES Cell Tolerance$368,801
R01 · FY2013 · AI · contact PI
Molecular Imaging of Cardiac Stem Cell Therapy$333,961
R01 · FY2013 · EB · contact PI